Jonathan Tegge

Overview

Jonathan Tegge received an average of $6K in total compensation at InMed Pharmaceuticals between 2023 and 2024.

Source: SEC filing on October 28, 2024.

Related executives

We found six more executives who work or worked at InMed Pharmaceuticals.

Eric Adams

InMed Pharmaceuticals

Chief Executive Officer

Michael Woudenberg

InMed Pharmaceuticals

Chief Operating Officer

Eric Hsu

InMed Pharmaceuticals

Senior Vice President, Preclinical Research & Development

Alexandra Mancini

InMed Pharmaceuticals

Senior Vice President, Clinical & Regulatory Affairs

Netta Jagpal

InMed Pharmaceuticals

Chief Financial Officer

Bruce Colwill

InMed Pharmaceuticals

Chief Financial Officer

News

You may also like